D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$420M |
| 2 |
Oracle
ORCL
|
+$406M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$307M |
| 4 |
Apple
AAPL
|
+$306M |
| 5 |
Meta Platforms (Facebook)
META
|
+$292M |
Top Sells
| 1 |
Amazon
AMZN
|
+$673M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$285M |
| 4 |
AT&T
T
|
+$255M |
| 5 |
NVIDIA
NVDA
|
+$243M |
Sector Composition
| 1 | Technology | 19.62% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Healthcare | 14.47% |
| 4 | Financials | 9.86% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Perrigo
PRGO
$3.07B
| $16.2M | 0.02% |
417,916
+22,069
| +6% | +$855K |
|
577
Pacira BioSciences
PCRX
$1.21B
| $16M | 0.02% |
372,207
+209,170
| +128% | +$9M |
|
578
SPX Corp
SPXC
$9.44B
| $15.9M | 0.02% |
569,399
-54,781
| -9% | -$1.53M |
|
579
Medpace
MEDP
$13.8B
| $15.9M | 0.02% |
299,465
-241,334
| -45% | -$12.8M |
|
580
Gildan
GIL
$8.21B
| $15.8M | 0.02% |
520,941
-916,013
| -64% | -$27.8M |
|
|
GHDX
581
DELISTED
Genomic Health, Inc.
GHDX
| $15.8M | 0.02% |
245,540
+145,547
| +146% | +$9.37M |
|
|
DHC
582
Diversified Healthcare Trust
DHC
$1.07B
| $15.8M | 0.02% |
1,347,967
+1,330,967
| +7,829% | +$15.6M |
|
583
Acuity Brands
AYI
$10.4B
| $15.8M | 0.02% |
137,225
+16,504
| +14% | +$1.9M |
|
|
AZPN
584
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $15.8M | 0.02% |
191,732
+130,339
| +212% | +$10.7M |
|
585
Treehouse Foods
THS
$896M
| $15.7M | 0.02% |
310,318
+101,679
| +49% | +$5.16M |
|
586
Essent Group
ESNT
$6.31B
| $15.7M | 0.02% |
459,980
-56,940
| -11% | -$1.95M |
|
|
AMAG
587
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $15.7M | 0.02% |
1,034,793
-13,856
| -1% | -$210K |
|
588
American Eagle Outfitters
AEO
$3.39B
| $15.7M | 0.02% |
+810,975
| New | +$15.7M |
|
589
World Kinect Corp
WKC
$1.43B
| $15.7M | 0.02% |
731,748
+68,948
| +10% | +$1.48M |
|
590
Oshkosh
OSK
$8.91B
| $15.6M | 0.02% |
255,000
+20,714
| +9% | +$1.27M |
|
591
QuidelOrtho
QDEL
$2B
| $15.6M | 0.02% |
319,514
-13,768
| -4% | -$672K |
|
592
Chemed
CHE
$6.63B
| $15.6M | 0.02% |
55,028
-43,239
| -44% | -$12.2M |
|
593
Fossil Group
FOSL
$162M
| $15.6M | 0.02% |
990,336
-686,780
| -41% | -$10.8M |
|
594
Healthcare Realty
HR
$6.42B
| $15.5M | 0.02% |
613,969
+560,160
| +1,041% | +$14.2M |
|
595
Pacific Biosciences
PACB
$375M
| $15.5M | 0.02% |
2,099,833
+1,837,321
| +700% | +$13.6M |
|
|
HRC
596
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $15.5M | 0.02% |
175,111
+74,525
| +74% | +$6.6M |
|
597
Avanos Medical
AVNS
$574M
| $15.5M | 0.02% |
346,095
+279,054
| +416% | +$12.5M |
|
598
Outfront Media
OUT
$3.12B
| $15.3M | 0.02% |
858,289
+731,516
| +577% | +$13M |
|
|
EGOV
599
DELISTED
NIC Inc
EGOV
| $15.2M | 0.02% |
1,221,277
+146,218
| +14% | +$1.82M |
|
|
WRK
600
DELISTED
WestRock Company
WRK
| $15.2M | 0.02% |
402,924
-809,428
| -67% | -$30.6M |
|